TALK KEYWORD INDEX
This page contains an index consisting of author-provided keywords.
| 1 | |
| 1H MRS | |
| 3 | |
| 3D-conformal radiation therapy | |
| A | |
| aa | |
| ACE inhibition | |
| advanced tumor models | |
| aging | |
| alanine | |
| Anti-PD-L1 | |
| artificial intelligence | |
| Atlas | |
| B | |
| bb | |
| BDSIM | |
| bioluminescence | |
| Biomarkers | |
| brain tumors | |
| breast cancer | |
| bystander effect | |
| C | |
| cachexia | |
| Cancer | |
| canines | |
| cardiac | |
| Cardiac strain | |
| cardiopulmonary system | |
| Cardiotoxicity | |
| CB-CT imaging | |
| cc | |
| cell cycle | |
| Cell specific analyses | |
| Cesium | |
| chemoradiotherapy | |
| chemotherapy | |
| CIRP | |
| Clinical trials | |
| clonogenic survival | |
| collagen | |
| Combination therapies | |
| Commissioning | |
| Computed Tomography | |
| contrast-enhanced computed tomography | |
| cross centre comparison | |
| D | |
| deep learning | |
| deterministic dose engine | |
| DNA damage response pathway | |
| Dose verification | |
| dosimetric uncertainties | |
| Dosimetry | |
| Dosimetry audits | |
| Dosimetry intercomparisons | |
| draining lymph node irradiation | |
| E | |
| Early detection | |
| eMRI/electron paramagnetic resonance imaging | |
| F | |
| fat loss | |
| FLASH | |
| FLASH radiation | |
| FLASH-RT | |
| Fractionated | |
| fractionation | |
| G | |
| Geometric distortion | |
| Glioblastoma | |
| glioma | |
| Gradient non-linearity | |
| H | |
| head and neck | |
| Head and Neck Cancer | |
| Hepatocellular Carcinoma | |
| high-precision irradiation | |
| histology | |
| I | |
| image guided irradiation | |
| Image registration | |
| image-guidance | |
| image-guided brain irradiation | |
| Image-guided mouse irradiation | |
| Image-guided radiation | |
| Imaging biomarkers | |
| Immune Infiltration | |
| Immunology | |
| immunotherapy | |
| In-Vivo | |
| in-vivo proton irradiation | |
| Inflammation | |
| intensity-modulated radiation therapy | |
| intestinal | |
| Intestinal stem cells | |
| Ionoacoustics | |
| K | |
| k1 | |
| k2 | |
| k3 | |
| L | |
| Late effects | |
| Linac | |
| long-term | |
| Long-term normal tissue toxicity | |
| lung cancer | |
| M | |
| Magnetic field inhomogeneity | |
| Magnetic Resonance | |
| Magnetic Resonance Imaging | |
| MALDI imaging | |
| Mechanical accuracy | |
| mesenchymal | |
| Metastasis | |
| metastatic tumor model | |
| Mice | |
| Micro-CT | |
| Microbeam radiation therapy | |
| Mini-beam | |
| Minibeam | |
| Minibeam radiation Therapy | |
| mitotic enrichment | |
| Molecular Dosimetry | |
| Monte Carlo | |
| monte carlo dose calculations | |
| Monte Carlo simulations | |
| Mouse brain proton irradiation | |
| Mouse models | |
| mouse organ segmentation | |
| Mouse phantom | |
| muscle loss | |
| N | |
| nanoparticle delivery | |
| neurogenic regions | |
| Neuroinflammation | |
| normal brain tissue | |
| Normal tissue | |
| normal tissue biology | |
| Normal tissue complications | |
| Normal tissue effects | |
| normal tissue models | |
| novel combination treatment approaches | |
| O | |
| organic nanoparticle + radiotherapy | |
| orthotopic | |
| Orthotopic glioblastoma models | |
| orthotopic mouse model | |
| orthotopic tumor | |
| orthotopic xenotransplant | |
| Oxygen guided radiotherapy | |
| Oxygen imaging | |
| oxygen-guided radiotherapy | |
| P | |
| Paediatric brain cancer | |
| pancreatic cancer | |
| passive and active detectors | |
| PBS | |
| pencil beam | |
| PET imaging | |
| phantoms | |
| positioning | |
| precision delivery | |
| preclinical | |
| Preclinical (in vivo) studies | |
| preclinical models | |
| Preclinical mouse studies | |
| preclinical proton research | |
| preclinical radiation research dosimetry | |
| preclinical radiotherapy | |
| preclinical treatment planning | |
| proton | |
| proton dose distribution | |
| proton facility | |
| proton FLASH | |
| Proton therapy | |
| protons | |
| Q | |
| Quality assurance | |
| R | |
| Radiation | |
| Radiation protection | |
| Radiation response | |
| radiation-induced injury | |
| Radiation-induced myocardial fibrosis | |
| Radiobiology | |
| radiodynamic therapy | |
| radioimmunotherapy | |
| Radioluminescence | |
| Radiomics | |
| radioresistance | |
| radioresistant tumors | |
| radiosensitization | |
| Radiotherapy | |
| radiotherapy-induced lymphopenia | |
| Real-time | |
| RECIST | |
| recovery | |
| Registration | |
| Relative biological effectiveness (RBE) | |
| reliability | |
| research facility | |
| S | |
| SARRP | |
| SARRP FLASH | |
| SFRT | |
| side-effects | |
| SIRMIO | |
| skin | |
| small animal | |
| Small animal IGRT | |
| Small animal irradiator | |
| Small animal radiotherapy | |
| Small-animal radiotherapy | |
| Spatial resolution | |
| standardisation | |
| stereotactic ablative radiotherapy | |
| stiffness | |
| Subvolume | |
| syngeneic animal model | |
| T | |
| T cells | |
| Temporal and Spatial Factors | |
| Thermoluminescent Dosimeter | |
| thoracic radiotherapy | |
| TLD Fading with Temperature | |
| TLD-100 behavior | |
| tomography | |
| Traceability | |
| translational | |
| Treatment planning | |
| Treatment Planning System | |
| treatment verification | |
| Tumor control | |
| Tumor hypoxia | |
| Tumour | |
| Tumour heterogeneity | |
| U | |
| Ultra-high dose radiation | |
| Ultra-high dose rate | |
| Ultra-high field | |
| V | |
| VEGF-A | |
| W | |
| workflow | |
| working parties | |
| X | |
| x-ray | |
| Xenograft | |